Milan Djukic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Milan Djukic has a total of 236 co-authors. Here are the top co-authors by number of shared publications:
Ida Jovanovic
School of Medicine, Belgrade + University Children's Hospital, Cardiology Department, Belgrade
13 shared publicationsSlobodan Ilic
School of medicine, Belgrade + University Children's Hospital, Department of Cardiac Surgery, Belgrade
10 shared publicationsIgor Stefanovic
University Children's Hospital, Department of Cardiology, Belgrade, Serbia
9 shared publicationsVojislav Parezanovic
School of Medicine, Belgrade + University Children's Hospital, Cardiology Department, Belgrade
9 shared publicationsIrena Vulicevic
University Childrens Hospital, Department of Pediatric Cardiac Surgery, Belgrade
8 shared publications- Igor Stefanovic
Medical Faculty, University of Belgrade, 11000 Belgrade, Serbia
7 shared publications
Latest Publications
- Open Access
- 18 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Adult ALCAPA presenting as NSTEMI: a multimodality imaging pathway to diagnosis – a case report
Background: Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is rarely diagnosed in adulthood and may cause myocardial infarction, ventricular dysfunction, arrhythmias, or sudden death. Case summary: A 27-year-old man presented with NSTEMI, LV dilatation, and LVEF approximately 40%. CMR demonstrated subendocardial ischaemic-pattern late gadolinium enhancement. Invasive angiography and CCTA showed markedly ectatic and tortuous coronary vessels, extensive collateralization, an anomalous LCA origin from the right pulmonary artery, and complex coronary–pulmonary and bronchial communications. Right-heart catheterization demonstrated Qp/Qs 1.89. The LCA was excised from the pulmonary artery and reimplanted into the ascending aorta. During nearly four years of postoperative follow-up, LV systolic function fluctuated and ventricular ectopy persisted. The latest TTE showed LVEF 46% and GLS −13.7%. Discussion: Adult survival with ALCAPA depends on extensive collateralization that preserves viability while perpetuating coronary steal and chronic myocardial injury. Multimodality imaging is essential to define this complex anatomy, characterize myocardial damage, and guide repair. Successful restoration of a dual coronary system does not eliminate the need for long-term surveillance of myocardial scar, LV remodelling, and ventricular arrhythmias. Long-term anticoagulation remains an individualized, evidence-limited decision.
- 18 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Case Reports
Open AccessAdult ALCAPA presenting as NSTEMI: a multimodality imaging pathway to diagnosis – a case report
Background: Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is rarely diagnosed in adulthood and may cause myocardial infarction, ventricular dysfunction, arrhythmias, or sudden death. Case summary: A 27-year-old man presented with NSTEMI, LV dilatation, and LVEF approximately 40%. CMR demonstrated subendocardial ischaemic-pattern late gadolinium enhancement. Invasive angiography and CCTA showed markedly ectatic and tortuous coronary vessels, extensive collateralization, an anomalous LCA origin from the right pulmonary artery, and complex coronary–pulmonary and bronchial communications. Right-heart catheterization demonstrated Qp/Qs 1.89. The LCA was excised from the pulmonary artery and reimplanted into the ascending aorta. During nearly four years of postoperative follow-up, LV systolic function fluctuated and ventricular ectopy persisted. The latest TTE showed LVEF 46% and GLS −13.7%. Discussion: Adult survival with ALCAPA depends on extensive collateralization that preserves viability while perpetuating coronary steal and chronic myocardial injury. Multimodality imaging is essential to define this complex anatomy, characterize myocardial damage, and guide repair. Successful restoration of a dual coronary system does not eliminate the need for long-term surveillance of myocardial scar, LV remodelling, and ventricular arrhythmias. Long-term anticoagulation remains an individualized, evidence-limited decision.
- Open Access
- 24 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 4911
Significance of the Echocardiographic Assessment of Longitudinal Left Ventricular Systolic Function in Children and Adolescents with Hypertrophic Cardiomyopathy
Background/Objectives: Hypertrophic cardiomyopathy (HCM) in childhood is associated with a risk of adverse cardiovascular events despite preserved left ventricular (LV) ejection fraction (EF). The aim of this study was to evaluate echocardiographic parameters of longitudinal LV systolic function and determine their relationship with cardiac magnetic resonance (CMR) findings and major adverse cardiovascular events (MACE) in children and adolescents with HCM. Methods: This single-centre prospective observational study enrolled 31 children and adolescents with HCM and preserved LV EF. Echocardiographic assessment included mitral annular plane systolic excursion (MAPSE), tissue Doppler mitral annulus systolic velocity (s′), mitral annular displacement index (MADI), and LV global longitudinal strain (GLS). Investigated CMR parameters encompassed LV mass, maximal wall thickness, and late gadolinium enhancement (LGE). Associations between echocardiographic and CMR findings were analyzed, and the discriminative value of longitudinal function parameters for MACE was assessed. Results: Impaired longitudinal systolic function was frequently detected in our cohort. Lower MAPSE and s′ z-scores were present in 61.3% of patients, reduced MADI in 96.8%, and reduced LV GLS in all subjects. Patients with MACE showed significantly lower MADI (p < 0.001) and worse LV GLS (p = 0.003). An exploratory LV GLS cut-off value of −12.1% showed discrimination for MACE in this cohort, with 75% sensitivity and 95.7% specificity. Echocardiographic parameters significantly correlated with CMR markers of hypertrophy and fibrosis, particularly LV GLS, which demonstrated the strongest associations with LV mass and the presence and extent of LGE. Conclusions: Echocardiographic parameters of longitudinal LV systolic function could contribute to closer clinical surveillance in children and adolescents with HCM. LV GLS may identify subtle myocardial dysfunction and provide exploratory prognostic information; however, its role in risk stratification requires prospective validation in larger pediatric HCM cohorts.
- 24 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 4911
Open AccessSignificance of the Echocardiographic Assessment of Longitudinal Left Ventricular Systolic Function in Children and Adolescents with Hypertrophic Cardiomyopathy
Background/Objectives: Hypertrophic cardiomyopathy (HCM) in childhood is associated with a risk of adverse cardiovascular events despite preserved left ventricular (LV) ejection fraction (EF). The aim of this study was to evaluate echocardiographic parameters of longitudinal LV systolic function and determine their relationship with cardiac magnetic resonance (CMR) findings and major adverse cardiovascular events (MACE) in children and adolescents with HCM. Methods: This single-centre prospective observational study enrolled 31 children and adolescents with HCM and preserved LV EF. Echocardiographic assessment included mitral annular plane systolic excursion (MAPSE), tissue Doppler mitral annulus systolic velocity (s′), mitral annular displacement index (MADI), and LV global longitudinal strain (GLS). Investigated CMR parameters encompassed LV mass, maximal wall thickness, and late gadolinium enhancement (LGE). Associations between echocardiographic and CMR findings were analyzed, and the discriminative value of longitudinal function parameters for MACE was assessed. Results: Impaired longitudinal systolic function was frequently detected in our cohort. Lower MAPSE and s′ z-scores were present in 61.3% of patients, reduced MADI in 96.8%, and reduced LV GLS in all subjects. Patients with MACE showed significantly lower MADI (p < 0.001) and worse LV GLS (p = 0.003). An exploratory LV GLS cut-off value of −12.1% showed discrimination for MACE in this cohort, with 75% sensitivity and 95.7% specificity. Echocardiographic parameters significantly correlated with CMR markers of hypertrophy and fibrosis, particularly LV GLS, which demonstrated the strongest associations with LV mass and the presence and extent of LGE. Conclusions: Echocardiographic parameters of longitudinal LV systolic function could contribute to closer clinical surveillance in children and adolescents with HCM. LV GLS may identify subtle myocardial dysfunction and provide exploratory prognostic information; however, its role in risk stratification requires prospective validation in larger pediatric HCM cohorts.
- Open Access
- 24 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 963
Prevalence and Predictors of Impaired Coronary Flow Velocity Reserve in Adolescents After Arterial Switch Operation
Background/Objectives: We assessed the prevalence of impaired coronary flow velocity reserve (CFVR) and aimed to identify echocardiographic and clinical predictors of coronary microvascular dysfunction in adolescents after neonatal arterial switch operation (ASO). Methods: This single-center, cross-sectional study included patients that underwent neonatal ASO for simple D-transposition of the great arteries (D-TGA) during 1998–2013. All patients were evaluated by echocardiography with global left ventricular strain measurement (GLS) and cardiac catheterization, including coronary angiography. Coronary flow velocity reserve was assessed by transthoracic Doppler echocardiography in the left anterior descending artery (LAD) using adenosine induced hyperemia. Patients were stratified into two groups according to CFVR: group with impaired CFVR (p = 0.025). Conclusions: Impaired CFVR appears to be frequently observed in adolescents after uncomplicated neonatal ASO for simple D-TGA. Importantly, impaired CFVR is associated with right ventricular dysfunction.
- 24 March 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (7) , 963
Open AccessPrevalence and Predictors of Impaired Coronary Flow Velocity Reserve in Adolescents After Arterial Switch Operation
Background/Objectives: We assessed the prevalence of impaired coronary flow velocity reserve (CFVR) and aimed to identify echocardiographic and clinical predictors of coronary microvascular dysfunction in adolescents after neonatal arterial switch operation (ASO). Methods: This single-center, cross-sectional study included patients that underwent neonatal ASO for simple D-transposition of the great arteries (D-TGA) during 1998–2013. All patients were evaluated by echocardiography with global left ventricular strain measurement (GLS) and cardiac catheterization, including coronary angiography. Coronary flow velocity reserve was assessed by transthoracic Doppler echocardiography in the left anterior descending artery (LAD) using adenosine induced hyperemia. Patients were stratified into two groups according to CFVR: group with impaired CFVR (p = 0.025). Conclusions: Impaired CFVR appears to be frequently observed in adolescents after uncomplicated neonatal ASO for simple D-TGA. Importantly, impaired CFVR is associated with right ventricular dysfunction.
- Open Access
Transcatheter Correction of Bilateral Partial Anomalous Pulmonary Venous Return with Intrapulmonary Dual Drainage: A Rare Entity
Partial anomalous pulmonary venous return (PAPVR) with dual drainage is a very rare congenital heart anomaly. We report the case of a 6-year-old boy with PAPVR in whom both upper pulmonary veins (PVs) drain anomalously into the systemic venous circulation, while maintaining preserved intrapulmonary collateral venous connections with the remaining pulmonary veins draining into the left atrium. Careful balloon occlusion testing of the anomalous PVs was performed, simultaneously with measurements of pulmonary pressures and control angiography, proving the absence of venous congestion in the upper lung fields during the pulmonary venous phase. Transcatheter occlusion using vascular plugs was safely and successfully performed.
Open AccessTranscatheter Correction of Bilateral Partial Anomalous Pulmonary Venous Return with Intrapulmonary Dual Drainage: A Rare Entity
Partial anomalous pulmonary venous return (PAPVR) with dual drainage is a very rare congenital heart anomaly. We report the case of a 6-year-old boy with PAPVR in whom both upper pulmonary veins (PVs) drain anomalously into the systemic venous circulation, while maintaining preserved intrapulmonary collateral venous connections with the remaining pulmonary veins draining into the left atrium. Careful balloon occlusion testing of the anomalous PVs was performed, simultaneously with measurements of pulmonary pressures and control angiography, proving the absence of venous congestion in the upper lung fields during the pulmonary venous phase. Transcatheter occlusion using vascular plugs was safely and successfully performed.
- Open Access
- 27 January 2026
- Published by MDPI AG in Preprints.org
Transcatheter Correction of Bilateral Partial Anomalous Pulmonary Venous Return with Intrapulmonary Dual Drainage: A Rare Entity
Partial anomalous pulmonary venous return (PAPVR) with dual drainage is a very rare congenital heart anomaly. We report the case of a 6-year-old boy with PAPVR in whom the both upper pulmonary veins (PVs) drain anomalously into the systemic venous circulation, while having preserved intrapulmonary collateral venous connection with remaining pulmonary veins draining into the left atrium. Careful balloon occlusion testing of the anomalous PVs was performed, simultaneously with measurements of pulmonary pressures and control angiography proving the absence of venous congestion in the upper lung fields during the pulmonary venous phase. Transcatheter occlusion using vascular plugs was safely and successfully performed.
- 27 January 2026
- Published by MDPI AG in Preprints.org
Open AccessTranscatheter Correction of Bilateral Partial Anomalous Pulmonary Venous Return with Intrapulmonary Dual Drainage: A Rare Entity
Partial anomalous pulmonary venous return (PAPVR) with dual drainage is a very rare congenital heart anomaly. We report the case of a 6-year-old boy with PAPVR in whom the both upper pulmonary veins (PVs) drain anomalously into the systemic venous circulation, while having preserved intrapulmonary collateral venous connection with remaining pulmonary veins draining into the left atrium. Careful balloon occlusion testing of the anomalous PVs was performed, simultaneously with measurements of pulmonary pressures and control angiography proving the absence of venous congestion in the upper lung fields during the pulmonary venous phase. Transcatheter occlusion using vascular plugs was safely and successfully performed.
- Open Access
- 26 January 2026
- Published by MDPI AG in Preprints.org
Prevalence and Predictors of Impaired Coronary Flow Velocity Reserve in Adolescents After Arterial Switch Operation
Background/Objectives: We assessed the prevalence of impaired coronary flow veloc-ity reserve (CFVR) and aimed to identify echocardiographic and clinical predictors of coronary microvascular dysfunction in adolescents after neonatal arterial switch op-eration (ASO). Methods: This single-center, cross-sectional study included patients that underwent neonatal ASO for simple D-transposition of the great arteries (D-TGA) during 1998-2013. All patients were evaluated by echocardiography with global left ventricu-lar strain measurement (GLS) and cardiac catheterization, including coronary angi-ography. Coronary flow velocity reserve was assessed by transthoracic Doppler echo-cardiography in the left anterior descending artery (LAD) using adenosine induced hyperemia. Patients were stratified into two groups according to CFVR: group with impaired CFVR (< 2.5) and group with normal CFVR (≥2.5). Spearman correlation was used to assess relationship between CFVR and echocardiographic variables. Binary lo-gistic regression was used to determine independent predictors of impaired CFVR. Results: Out of 48 patients included (median age 16 years, age range 13 to 23 years, 71% male), impaired CFVR was found in 21 patients (44%). These patients had de-creased longitudinal tricuspid annular plane systolic excursion (TAPSE), greater Z-scores for left ventricular end-systolic dimensions and higher mean pulmonary ar-tery pressures (mPAP). CFVR showed modest but significant positive correlations with tricuspid annular plane systolic excursion (TAPSE). Left pulmonary artery branch ste-nosis, reduced TAPSE and mPAP≥ 20 mmHg, were significantly associated with im-paired CFVR, while decreased TAPSE remained independent predictor in multivaria-ble analysis (odds ratio 5.6, 95% confidence interval 1.24-25.26, p=0.025). Conclusions: Impaired CFVR is highly prevalent in adolescents after neonatal ASO. Importantly, impaired CFVR is associated with right ventricular dysfunction.
- 26 January 2026
- Published by MDPI AG in Preprints.org
Open AccessPrevalence and Predictors of Impaired Coronary Flow Velocity Reserve in Adolescents After Arterial Switch Operation
Background/Objectives: We assessed the prevalence of impaired coronary flow veloc-ity reserve (CFVR) and aimed to identify echocardiographic and clinical predictors of coronary microvascular dysfunction in adolescents after neonatal arterial switch op-eration (ASO). Methods: This single-center, cross-sectional study included patients that underwent neonatal ASO for simple D-transposition of the great arteries (D-TGA) during 1998-2013. All patients were evaluated by echocardiography with global left ventricu-lar strain measurement (GLS) and cardiac catheterization, including coronary angi-ography. Coronary flow velocity reserve was assessed by transthoracic Doppler echo-cardiography in the left anterior descending artery (LAD) using adenosine induced hyperemia. Patients were stratified into two groups according to CFVR: group with impaired CFVR (< 2.5) and group with normal CFVR (≥2.5). Spearman correlation was used to assess relationship between CFVR and echocardiographic variables. Binary lo-gistic regression was used to determine independent predictors of impaired CFVR. Results: Out of 48 patients included (median age 16 years, age range 13 to 23 years, 71% male), impaired CFVR was found in 21 patients (44%). These patients had de-creased longitudinal tricuspid annular plane systolic excursion (TAPSE), greater Z-scores for left ventricular end-systolic dimensions and higher mean pulmonary ar-tery pressures (mPAP). CFVR showed modest but significant positive correlations with tricuspid annular plane systolic excursion (TAPSE). Left pulmonary artery branch ste-nosis, reduced TAPSE and mPAP≥ 20 mmHg, were significantly associated with im-paired CFVR, while decreased TAPSE remained independent predictor in multivaria-ble analysis (odds ratio 5.6, 95% confidence interval 1.24-25.26, p=0.025). Conclusions: Impaired CFVR is highly prevalent in adolescents after neonatal ASO. Importantly, impaired CFVR is associated with right ventricular dysfunction.
- Open Access
- 30 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 915
Acceptability and Palatability of Novel Orodispersible Minitablets of Enalapril in Children up to the Age of 6 with Heart Failure
Background: Angiotensin-converting enzyme inhibitors, such as enalapril, are foundational in treating pediatric heart failure. However, they are often administered off-label to young children using extemporaneous formulations. This study, conducted as part of the EU-funded Labeling of Enalapril from Neonates up to Adolescents (LENA) project, aimed to evaluate the acceptability and palatability of an age-appropriate enalapril orodispersible minitablet (ODMT). These factors are critical for ensuring adherence, efficacy, and safety in pediatric patients. Methods: An 8-week trial was conducted in children with heart failure caused by dilated cardiomyopathy or congenital heart disease. Enalapril ODMTs (0.25 mg or 1.0 mg) were dose-titrated and administered to 38 children aged 0–6 months and 22 children aged 6 months to 6 years. This study aimed to assess its acceptability and palatability, key factors contributing to adherence, and therefore, efficacy and safety. Results: Across all 169 assessments in 38 children aged 0–6 months and 22 aged 6 months to 6 years, complete or partial swallowability was observed, and the acceptability rate was 100%. There were no cases of choking, inhalation/coughing, or spitting out. A favorable or neutral rating was observed in 96% of palatability assessments based on observations of facial expressions. Acceptability and palatability were higher in subjects aged 6 months–6 years than 0–6 months, with no significant influence from repeated administration. Conclusions: Enalapril ODMTs are widely accepted and well-tolerated among young children, including neonates, with heart failure. These findings suggest that ODMTs are a suitable and effective method for administering pediatric medicinal products.
- 30 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (3) , 915
Open AccessAcceptability and Palatability of Novel Orodispersible Minitablets of Enalapril in Children up to the Age of 6 with Heart Failure
Background: Angiotensin-converting enzyme inhibitors, such as enalapril, are foundational in treating pediatric heart failure. However, they are often administered off-label to young children using extemporaneous formulations. This study, conducted as part of the EU-funded Labeling of Enalapril from Neonates up to Adolescents (LENA) project, aimed to evaluate the acceptability and palatability of an age-appropriate enalapril orodispersible minitablet (ODMT). These factors are critical for ensuring adherence, efficacy, and safety in pediatric patients. Methods: An 8-week trial was conducted in children with heart failure caused by dilated cardiomyopathy or congenital heart disease. Enalapril ODMTs (0.25 mg or 1.0 mg) were dose-titrated and administered to 38 children aged 0–6 months and 22 children aged 6 months to 6 years. This study aimed to assess its acceptability and palatability, key factors contributing to adherence, and therefore, efficacy and safety. Results: Across all 169 assessments in 38 children aged 0–6 months and 22 aged 6 months to 6 years, complete or partial swallowability was observed, and the acceptability rate was 100%. There were no cases of choking, inhalation/coughing, or spitting out. A favorable or neutral rating was observed in 96% of palatability assessments based on observations of facial expressions. Acceptability and palatability were higher in subjects aged 6 months–6 years than 0–6 months, with no significant influence from repeated administration. Conclusions: Enalapril ODMTs are widely accepted and well-tolerated among young children, including neonates, with heart failure. These findings suggest that ODMTs are a suitable and effective method for administering pediatric medicinal products.
- Open Access
- 23 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 4976
Clinical and Hemodynamic Outcomes with Enalapril Orodispersible Minitablets in Young Children with Heart Failure Due to Congenital Heart Disease
Background: The angiotensin-converting enzyme inhibitor (ACEI) enalapril is often administered to infants and young children with heart failure (HF) in various dosing regimens and formulations not adapted for their age. Methods: This prospective, two-center, open-label 8-week study evaluated an age-appropriate formulation of orodispersible minitablets (ODMTs) of enalapril (0.25 mg and 1 mg) in children aged 0 to 6 years with HF due to congenital heart disease. An age/weight-based dosing schedule was followed. Measures of echocardiographic parameters, blood pressure, heart rate, modified Ross score, and biochemistry were obtained over the 8-week period. The following two groups were assessed: ACEI-naïve and ACEI-pretreated patients. Results: In total, 53 children (age range of 0.05 to 4.8 years) were enrolled and 29 were ACEI-naïve. The average enalapril dose was 0.098 mg/kg (0.06–0.17 mg/kg) in the naïve group and 0.15 mg/kg (0.07–0.3 mg/kg) in pretreated patients. After 8 weeks, the modified Ross score and left ventricular diastolic dimension (LVD) z-score showed a significant decrease in both groups (p < 0.005). During 8 weeks follow-up, there were no difference in the z-scores for the systolic blood pressure (p = 0.071) or heart rate (p = 0.146). Conclusions: Pediatric patients treated with ODMTs of enalapril for 8 weeks had favorable improvements in LVD and HF symptoms.
- 23 August 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (17) , 4976
Open AccessClinical and Hemodynamic Outcomes with Enalapril Orodispersible Minitablets in Young Children with Heart Failure Due to Congenital Heart Disease
Background: The angiotensin-converting enzyme inhibitor (ACEI) enalapril is often administered to infants and young children with heart failure (HF) in various dosing regimens and formulations not adapted for their age. Methods: This prospective, two-center, open-label 8-week study evaluated an age-appropriate formulation of orodispersible minitablets (ODMTs) of enalapril (0.25 mg and 1 mg) in children aged 0 to 6 years with HF due to congenital heart disease. An age/weight-based dosing schedule was followed. Measures of echocardiographic parameters, blood pressure, heart rate, modified Ross score, and biochemistry were obtained over the 8-week period. The following two groups were assessed: ACEI-naïve and ACEI-pretreated patients. Results: In total, 53 children (age range of 0.05 to 4.8 years) were enrolled and 29 were ACEI-naïve. The average enalapril dose was 0.098 mg/kg (0.06–0.17 mg/kg) in the naïve group and 0.15 mg/kg (0.07–0.3 mg/kg) in pretreated patients. After 8 weeks, the modified Ross score and left ventricular diastolic dimension (LVD) z-score showed a significant decrease in both groups (p < 0.005). During 8 weeks follow-up, there were no difference in the z-scores for the systolic blood pressure (p = 0.071) or heart rate (p = 0.146). Conclusions: Pediatric patients treated with ODMTs of enalapril for 8 weeks had favorable improvements in LVD and HF symptoms.
- Open Access
- 1 January 2024
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 152 (11-12) , 610-614
Severe renovascular hypertension in an asymptomatic child - 11 years of follow up
Introduction. Renovascular hypertension is a rare cause of arterial hypertension in the pediatric population. The aim of this report was to present the treatment outcome in a girl with severe stenosis of the renal artery on a solitary kidney. Case outline. A 6.5-year-old girl, otherwise healthy, was found to be highly hypertensive (up to 200/140 mmHg) during a systematic examination for school enrollment. The imaging evaluation revealed that she had a single kidney with critical renal artery stenosis. Medication with three antihypertensive drugs was unsuccessful. The angioplasty attempt was complicated by artery wall dissection and the pseudoaneurysm development. This complication was treated surgically with an autologous saphenous vein graft by-pass. Postoperatively, acute kidney injury developed, which required continuous renal replacement therapy for two days, followed by hemorrhagic shock and the need for reintervention with retroperitoneal hematoma evacuation. After three years, aneurismal dilated vein graft was replaced by a synthetic one (PTFE) in London. Angioplasty of the synthetic graft was performed twice due to the development of proximal stenosis and restenosis. After 11 years of follow-up, the girl has well controlled blood pressure under two antihypertensives, with normal renal function without proteinuria. Conclusion. This case illustrates that angioplasty for single artery stenosis in children is a high-risk procedure, which may result in an aneurism formation or bleeding and a need for several kidney revascularization procedures. In order to preserve kidney function, it requires a serious multidisciplinary approach by nephrologists, interventional radiologists/cardiologists, and vascular surgeons.
- 1 January 2024
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 152 (11-12) , 610-614
Open AccessSevere renovascular hypertension in an asymptomatic child - 11 years of follow up
Introduction. Renovascular hypertension is a rare cause of arterial hypertension in the pediatric population. The aim of this report was to present the treatment outcome in a girl with severe stenosis of the renal artery on a solitary kidney. Case outline. A 6.5-year-old girl, otherwise healthy, was found to be highly hypertensive (up to 200/140 mmHg) during a systematic examination for school enrollment. The imaging evaluation revealed that she had a single kidney with critical renal artery stenosis. Medication with three antihypertensive drugs was unsuccessful. The angioplasty attempt was complicated by artery wall dissection and the pseudoaneurysm development. This complication was treated surgically with an autologous saphenous vein graft by-pass. Postoperatively, acute kidney injury developed, which required continuous renal replacement therapy for two days, followed by hemorrhagic shock and the need for reintervention with retroperitoneal hematoma evacuation. After three years, aneurismal dilated vein graft was replaced by a synthetic one (PTFE) in London. Angioplasty of the synthetic graft was performed twice due to the development of proximal stenosis and restenosis. After 11 years of follow-up, the girl has well controlled blood pressure under two antihypertensives, with normal renal function without proteinuria. Conclusion. This case illustrates that angioplasty for single artery stenosis in children is a high-risk procedure, which may result in an aneurism formation or bleeding and a need for several kidney revascularization procedures. In order to preserve kidney function, it requires a serious multidisciplinary approach by nephrologists, interventional radiologists/cardiologists, and vascular surgeons.
- 1 April 2019
- Published by Elsevier in La Presse Médicale
- Vol. 48 (4) , 468-469
Endovascular treatment for multiple aortic narrowings in a patient with Takayasu arteritis
- 1 April 2019
- Published by Elsevier in La Presse Médicale
- Vol. 48 (4) , 468-469
Endovascular treatment for multiple aortic narrowings in a patient with Takayasu arteritis